Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

European Medicines Agency
News & Press Releases  
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021 (new)
PRAC, Last updated: 09/07/2021

 

News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis (new)
PRAC, Last updated: 09/07/2021

 

News: EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome (new)
PRAC, Last updated: 09/07/2021
EMA’s safety committee (PRAC) has recommended that people who have previously had capillary leak syndrome must not be vaccinated with COVID-19 Vaccine Janssen. The Committee also recommended that capillary leak syndrome should be added to the product information as a new side effect of the vaccine, together with a warning to raise awareness among healthcare professionals and patients of this risk…

 

::::::

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
COVID-19 in children and the role of school settings in transmission – second update
Technical report
8 Jul 2021
The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, focusing in particular on the experience in EU/EEA countries since the beginning of the pandemic. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing, and the effectiveness and impacts of school closures. This document draws upon and updates evidence presented in the previous reports from ECDC on this topic, which were published in August 2020 and December 2020. This report does not consider educational settings related to young adults or adults, such as universities or vocational schools or any school with overnight stays, such as boarding schools.

 

::::::

::::::

https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

European Commission
https://ec.europa.eu/commission/presscorner/home/en
Statement 10 July 2021
Statement by President von der Leyen on the EU reaching the milestone of vaccine deliveries to vaccinate 70% of EU adults
I have good news for our European citizens today…The EU has kept its word.

This week-end, we have delivered enough vaccines to Member States to be in a position to vaccinate fully at least 70% of EU adults still this month….By tomorrow, some 500 million vaccine doses will have been distributed right across the regions of the European Union…The EU delivers.

Our vaccination campaign has accelerated tremendously since the beginning of the year…Our joint approach is a success…We will only come out of this crisis together.

COVID-19 is not yet defeated…But we are prepared to deliver more vaccines, including against new variants. Now, Member States must do everything, to increase vaccinations…Only then will we be safe.

Press release 9 July 2021
Republic of Senegal and Team Europe agree to build a manufacturing plant to produce vaccines against COVID-19 and other endemic diseases
Producing COVID-19 vaccines in Africa came one step closer today after Team Europe formally agreed to support large-scale investment in vaccine production by the Institut Pasteur in Dakar, alongside other support measures.